BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19427494)

  • 1. Hypertension, systolic blood pressure, and large arteries.
    Safar ME
    Med Clin North Am; 2009 May; 93(3):605-19, Table of Contents. PubMed ID: 19427494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification.
    Safar ME; Blacher J; Protogerou A; Achimastos A
    J Hypertens; 2008 Jan; 26(1):130-7. PubMed ID: 18090550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From 'optimal' to 'borderline' blood pressure in subjects under chronic antihypertensive therapy.
    Vergnaud AC; Protogerou AD; Blacher J; Safar ME
    J Hypertens; 2008 Jan; 26(1):138-44. PubMed ID: 18090551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive therapy and de-stiffening of the arteries.
    Safar ME; Jankowski P
    Expert Opin Pharmacother; 2010 Nov; 11(16):2625-34. PubMed ID: 20977399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of arterial wall properties in the pathogenesis of systolic hypertension.
    London GM
    Am J Hypertens; 2005 Jan; 18(1 Pt 2):19S-22S. PubMed ID: 15683728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics.
    Koumaras C; Tzimou M; Stavrinou E; Griva T; Gossios TD; Katsiki N; Athyros VG; Mikhailidis DP; Karagiannis A
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):143-56. PubMed ID: 22540323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of the central pulse pressure is useful for detecting cardiac overload during antiadrenergic treatment: the Japan Morning Surge 1 study.
    Matsui Y; Eguchi K; Shibasaki S; Ishikawa J; Hoshide S; Pickering TG; Shimada K; Kario K;
    J Hypertens; 2008 Oct; 26(10):1928-34. PubMed ID: 18806616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shear stress as target to reduce atherosclerosis progression in hypertensive patients.
    Marfella R; Bologna C; Quaranta E; Paolisso G
    Am J Hypertens; 2008 Jul; 21(7):729. PubMed ID: 18584017
    [No Abstract]   [Full Text] [Related]  

  • 9. Central blood pressure measurement may improve risk stratification.
    Sharman J; Stowasser M; Fassett R; Marwick T; Franklin S
    J Hum Hypertens; 2008 Dec; 22(12):838-44. PubMed ID: 18596719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the arterial wall, but what is the target?
    Shantsila E; Lim HS
    J Hum Hypertens; 2009 Jan; 23(1):1-3. PubMed ID: 18509342
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate.
    Williams B; Lacy PS;
    J Am Coll Cardiol; 2009 Aug; 54(8):705-13. PubMed ID: 19679248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive pharmacological agents: beyond their lowering blood pressure effects.
    Miatello RM
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):521-3. PubMed ID: 16309575
    [No Abstract]   [Full Text] [Related]  

  • 13. Large arteries in hypertension. Pharmacological and therapeutic aspects.
    Safar ME
    Pathol Biol (Paris); 1999 Sep; 47(7):738-43. PubMed ID: 10522264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral arterial disease and isolated systolic hypertension: the ATTEST study.
    Safar ME; Priollet P; Luizy F; Mourad JJ; Cacoub P; Levesque H; Benelbaz J; Michon P; Herrmann MA; Blacher J
    J Hum Hypertens; 2009 Mar; 23(3):182-7. PubMed ID: 18830251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].
    Kochsiek K; Fritsche H
    Arzneimittelforschung; 1966 Sep; 16(9):1154-60. PubMed ID: 6014733
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulse pressure, arterial stiffness and wave reflections (augmentation index) as cardiovascular risk factors in hypertension.
    Safar ME
    Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):13-24. PubMed ID: 19124404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern antihypertensive therapy in the light of arterial vascular function].
    Nürnberger J; Philipp T
    Dtsch Med Wochenschr; 2006 Nov; 131(46):2610-5. PubMed ID: 17096309
    [No Abstract]   [Full Text] [Related]  

  • 18. Brachial-brachial index of systolic blood pressure in the patients under anti-hypertensive therapy.
    Sun H; Li P; Su H; Wang W; Wang J; Hu W; Li J; Liu Y; Cheng X
    Int J Cardiol; 2014 Jul; 174(3):802-4. PubMed ID: 24814541
    [No Abstract]   [Full Text] [Related]  

  • 19. Central hemodynamics for risk reduction strategies: additive value over and above brachial blood pressure.
    Rinaldi ER; Yannoutsos A; Borghi C; Safar ME; Blacher J
    Curr Pharm Des; 2015; 21(6):730-6. PubMed ID: 25341860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse pressure, heart rate, and drug treatment of hypertension.
    Safar ME
    Curr Hypertens Rep; 2004 Jun; 6(3):190-4. PubMed ID: 15128470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.